Position in PFE
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$24,080
-$4,000 QoQ
Shares Held
1,000
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#2,691
of 2,821 holders
Holding Since
Dec 2021
14 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Gould Capital, LLC holds $5,361,370 across 4 Drug Manufacturers - General names. PFE ranks #4 (0.4% of the industry book) .
All Filings in PFE
Export CSV
14 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $24,080 | 1,000 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $28,080 | 1,000 | Shares | Sole | 2026-05-18 | |
| 2025-12-31 | $24,900 | 1,000 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $25,480 | 1,000 | Shares | Sole | 2025-11-17 | |
| 2025-06-30 | $24,240 | 1,000 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $25,340 | 1,000 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $26,530 | 1,000 | Shares | Sole | 2025-02-21 | |
| 2024-09-30 | $14,672 | 507 | Shares | Sole | 2024-11-18 | |
| 2024-06-30 | $13,990 | 500 | Shares | Sole | 2024-08-15 | |
| 2024-03-31 | $13,875 | 500 | Shares | Sole | 2024-05-13 | |
| 2022-09-30 | $1,750 | 40 | Shares | Sole | 2022-11-23 | |
| 2022-06-30 | $2,097 | 40 | Shares | Sole | 2022-08-03 | |
| 2022-03-31 | $2,070 | 40 | Shares | Sole | 2022-07-21 | |
| 2021-12-31 | $31,119 | 527 | Shares | Sole | 2022-02-14 | |
| No filing history on record for this holder in this stock. | ||||||